Results 51 to 60 of about 2,795,372 (389)
Dynamic and multi-pharmacophore modeling for designing polo-box domain inhibitors. [PDF]
The polo-like kinase 1 (Plk1) is a critical regulator of cell division that is overexpressed in many types of tumors. Thus, a strategy in the treatment of cancer has been to target the kinase activity (ATPase domain) or substrate-binding domain (Polo-box
Lee, Keun Woo+4 more
core +3 more sources
The urotensin receptor (UT receptor), a G-protein-coupled receptor mediating urotensin-II and urotensin-II-related peptide signaling in the urotensinergic system, has multiple pharmacological activities.
Na Li+9 more
doaj +1 more source
Iran Virtual Screening (IranVScreen): An Integrated Virtual Screening Interface
Background: Virtual screening (VS), as a computational technique, is being used widely in drug discovery research. One of the widely used VS methods is based on the docking of every ligand structure in a specific macromolecule. Multiple popular VS tools do not provide a graphic user interface (GUI).
Majid Jafari Sabet+3 more
openaire +2 more sources
Discovery of Novel IDH1 Inhibitor Through Comparative Structure-Based Virtual Screening
IDH1 mutations occur in about 20–30% of gliomas and are a promising target for the treatment of cancer. In the present study, the performance of aIDH1R132H was verified via glide-docking-based virtual screening. On the basis of the two crystal structures
Yuwei Wang+10 more
doaj +1 more source
The influence of the negative-positive ratio and screening database size on the performance of machine learning-based virtual screening. [PDF]
The machine learning-based virtual screening of molecular databases is a commonly used approach to identify hits. However, many aspects associated with training predictive models can influence the final performance and, consequently, the number of hits ...
Rafał Kurczab, Andrzej J Bojarski
doaj +1 more source
Background: In the past decade, several antibodies directed against the PD-1/PD-L1 interaction have been approved. However, therapeutic antibodies also exhibit some shortcomings. Using small molecules to regulate the PD-1/PD-L1 pathway may be another way
Lianxiang Luo+3 more
semanticscholar +1 more source
The emergence and rapid spread of SARS-CoV-2, the pathogen of COVID-19, have caused a worldwide public health crisis. The SARS-CoV-2 main protease (Mpro) is an essential enzyme for the virus and therefore an appealing target for the development of ...
Shuhua G. Li+9 more
doaj +1 more source
A Multiple Classifier System Identifies Novel Cannabinoid CB2 Receptor Ligands [PDF]
open access articleDrugs have become an essential part of our lives due to their ability to improve people’s health and quality of life. However, for many diseases, approved drugs are not yet available or existing drugs have undesirable side effects ...
Burggraaff, Lindsey+8 more
core +3 more sources
The rapidly spreading, highly contagious and pathogenic SARS-coronavirus 2 (SARS-CoV-2) associated Coronavirus Disease 2019 (COVID-19) has been declared as a pandemic by the World Health Organization (WHO).
S. Choudhary, Y. Malik, S. Tomar
semanticscholar +1 more source
Significance Drug repurposing effort for treatment of a new disease, such as COVID-19, usually starts from a virtual screening of existing drugs, followed by experimental validation, but the actual hit rate is generally rather low with traditional ...
Zhe Li+16 more
semanticscholar +1 more source